Table 1.
Half maximal inhibitory concentration values for SAHA and gefitinib (μM)
| Cell lines | IC50 SAHA | IC50 gefitinib | HPV status |
|---|---|---|---|
| UM-SCC-4 | 2.23 | 2.51 | − |
| UM-SCC-6 | 3.46 | 0.04 | − |
| UM-SCC-10A | 4.74 | 0.47 | − |
| UM-SCC-18 | 0.84 | 0.0089 | − |
| UM-SCC-19 | 2.44 | 0.98 | − |
| UM-SCC-23 | 1.04 | 2.57 | − |
| UM-SCC-47 | 3.75 | 8.43 | + |
| UPCI:SCC-90 | 1.55 | 0.37 | + |
| UM-SCC-104 | 1.84 | 0.058 | + |
| UPCI:SCC-154 | 2.44 | 14.3 | + |
| UD-SCC-2 | 5.28 | 6.96 | + |
| 93-VU147T | 2.32 | 0.13 | + |
Mean of at least three different experiments done in duplicate
IC50 half maximal inhibitory concentration, HPV human papillomavirus